Portfolio Co. Vectron Biosolutions Partners with Plant-Based Foods Manufacturer portfolioDynamk CapitalOctober 26, 2022
Dynamk Capital makes Inc. Magazine 2022 Founder-Friendly Investors list Dynamk CapitalOctober 4, 2022Dynamk Capital
Daniella Kranjac nominated for "Lifetime Luminary" award at Biotech Week Boston Dynamk CapitalSeptember 13, 2022
Portfolio Co. RoosterBio and AGC Biologics Announce Collaboration portfolioDynamk CapitalAugust 23, 2022
Dynamk Capital Co-Leads $21M Vernal Biosciences round along with Ampersand Capital Partners portfolioDynamk CapitalJune 2, 2022
Bionter AG secures $3 Million in Series Seed Financing Led by Dynamk Capital portfolioDynamk CapitalApril 27, 2022
Portfolio Company Xcellbio expands Labcorp Collaboration for Cell & Gene Therapies portfolioDynamk CapitalApril 21, 2022
Portfolio Company Lightspeed Microscopy, Inc. Rebrands to Reflect Expanded Offering and Vision Dynamk CapitalFebruary 3, 2022
Dynamk Capital Joins World-Class Syndicate of LS Investors Participating in Xcellbio’s $27.5 Series B Round Dynamk CapitalJanuary 19, 2022
Kayo announces Daniella Kranjac, Dynamk Capital as a Top 22 in ‘22: Women in Life Sciences Dynamk CapitalJanuary 4, 2022
Virica Biotech Raises Series A Financing and Expands Operations to Support Manufacturing of Viral Medicines Dynamk CapitalOctober 4, 2021
Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform portfolioDynamk CapitalSeptember 29, 2021
Vectron Biosolutions to Boost Protein Production Offering with Acquisition of Secretion Platform from T3S Technologies and $2.7M Series A Financing Round Dynamk CapitalJune 17, 2021
